1.Chemotherapy including MCNU for the treatment of terminal phase chronic myelogenous leukemia.
Dong Wook KIM ; Hee Jea KIM ; Hee Yul KIM ; Ki Dong YOO ; Jong Wook LEE ; Jong Yul JIN ; Chi Hwa HAN ; Woo Sung MIN ; Jong Won PARK ; Choon Choo KIM ; Dong Jib KIM
Journal of the Korean Cancer Association 1993;25(2):247-251
No abstract available.
Drug Therapy*
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
4.The Modified Method of Splenic Irradiation.
Su Mi CHUNG ; Hong Seok JANG ; Ihl Bohng CHOI ; Choon Yul KIM ; Yong Whee BAHK
Journal of the Korean Society for Therapeutic Radiology 1988;6(2):259-262
Splenic irradiation in chronic myelogenous leukemia is reserved for patients who have painful splenomegaly despite chemotherapy and/or inoperable splenomegaly because of huge size. The role of splenic irradiation is diminution of painful splenomegaly and indirect effect of splenic irradiation on unirradiated hematopoietic and lymphoreticular tissue such as reduction of leukocyte count and increase of hemoglobin level. We report on a useful clinical method for splenic irradiation in chronic myelogenous leukemia. We have used sonography as the tool of simulation. The portal size using modified method is smaller than the field size of conventional simulation, and so this method suggests that useful to irradiation of huge splenomegaly, effective shielding of critical organ and the downfall of complication during irradiation of spleen.
Drug Therapy
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
Leukocyte Count
;
Spleen
;
Splenomegaly
5.Hidden “Preleukemic Phase” of Chronic Myeloid Leukemia Presenting Without Leukocytosis in the Peripheral Blood Unrelated to Chemotherapy in a Patient Diagnosed With Diffuse Large B Cell Lymphoma.
Dong Won YOO ; Sang Hyuk PARK ; Jongyoun YI ; In Suk KIM ; Hyung Hoi KIM ; Chulhun L CHANG ; Eun Yup LEE
Annals of Laboratory Medicine 2017;37(5):443-445
No abstract available.
Drug Therapy*
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
;
Leukocytosis*
;
Lymphoma, B-Cell*